{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T02:11:07Z","timestamp":1795227067537,"version":"4.10.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T00:00:00Z","timestamp":1576713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Uterine adenomyosis is a benign disorder that often co-occurs with endometriosis and\/or leiomyoma, and impairs quality of life. The genomic features of adenomyosis are unknown. Here we apply next-generation sequencing to adenomyosis (70 individuals and 192 multi-regional samples), as well as co-occurring leiomyoma and endometriosis, and find recurring <jats:italic>KRAS<\/jats:italic> mutations in 26\/70 (37.1%) of adenomyosis cases. Multi-regional sequencing reveals oligoclonality in adenomyosis, with some mutations also detected in normal endometrium and\/or co-occurring endometriosis. <jats:italic>KRAS<\/jats:italic> mutations are more frequent in cases of adenomyosis with co-occurring endometriosis, low progesterone receptor (PR) expression, or progestin (dienogest; DNG) pretreatment. DNG\u2019s anti-proliferative effect is diminished via epigenetic silencing of <jats:italic>PR<\/jats:italic> in immortalized cells with mutant <jats:italic>KRAS<\/jats:italic>. Our genomic analyses suggest that adenomyotic lesions frequently contain <jats:italic>KRAS<\/jats:italic> mutations that may reduce DNG efficacy, and that adenomyosis and endometriosis may share molecular etiology, explaining their co-occurrence. These findings could lead to genetically guided therapy and\/or relapse risk assessment after uterine-sparing surgery.<\/jats:p>","DOI":"10.1038\/s41467-019-13708-y","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T11:02:52Z","timestamp":1576753372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1484-2228","authenticated-orcid":false,"given":"Satoshi","family":"Inoue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0241-9780","authenticated-orcid":false,"given":"Yasushi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7408-7298","authenticated-orcid":false,"given":"Toshihide","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamato","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3148-9243","authenticated-orcid":false,"given":"Taiki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1769-403X","authenticated-orcid":false,"given":"Tohru","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Ikemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5491-3871","authenticated-orcid":false,"given":"Ayumi","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1599-5800","authenticated-orcid":false,"given":"Kengo","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Osuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsutoshi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Osuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9126-3361","authenticated-orcid":false,"given":"Yasuhisa","family":"Terao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Kawazu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Mano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,19]]},"reference":[{"key":"13708_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.rbmo.2017.06.016","volume":"35","author":"S Vannuccini","year":"2017","unstructured":"Vannuccini, S. et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod. BioMed. Online 35, 592\u2013601 (2017).","journal-title":"Reprod. BioMed. Online"},{"key":"13708_CR2","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.fertnstert.2012.06.029","volume":"98","author":"RO Burney","year":"2012","unstructured":"Burney, R. O. & Giudice, L. C. Pathogenesis and pathophysiology of endometriosis. Fertil. Steril. 98, 511\u2013519 (2012).","journal-title":"Fertil. Steril."},{"key":"13708_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ejogrb.2014.08.016","volume":"181","author":"N Di Donato","year":"2014","unstructured":"Di Donato, N. et al. Prevalence of adenomyosis in women undergoing surgery for endometriosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 181, 289\u2013293 (2014).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"13708_CR4","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/humrep\/dex088","volume":"32","author":"C Chapron","year":"2017","unstructured":"Chapron, C. et al. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes. Hum. Reprod. 32, 1393\u20131401 (2017).","journal-title":"Hum. Reprod."},{"key":"13708_CR5","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/jog.12635","volume":"41","author":"A\u0130 G\u00fczel","year":"2015","unstructured":"G\u00fczel, A. \u0130. et al. Risk factors for adenomyosis, leiomyoma and concurrent adenomyosis and leiomyoma. J. Obstet. Gynaecol. Res. 41, 932\u2013937 (2015).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"13708_CR6","first-page":"3430","volume":"16","author":"W Yu","year":"2018","unstructured":"Yu, W., Liu, G., Liu, C. & Zhang, Z. Recurrence-associated factors of laparoscopic adenomyomectomy for severely symptomatic adenomyoma. Oncol. Lett. 16, 3430\u20133438 (2018).","journal-title":"Oncol. Lett."},{"key":"13708_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/09513590.2016.1205580","volume":"33","author":"AR Han","year":"2017","unstructured":"Han, A. R., Lee, T. H., Kim, S. & Lee, H. Y. Risk factors and biomarkers for the recurrence of ovarian endometrioma: about the immunoreactivity of progesterone receptor isoform B and nuclear factor kappa B. Gynecol. Endocrinol. 33, 70\u201374 (2017).","journal-title":"Gynecol. Endocrinol."},{"key":"13708_CR8","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1111\/jog.13703","volume":"44","author":"KH Lee","year":"2018","unstructured":"Lee, K. H. et al. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis. J. Obstet. Gynaecol. Res. 44, 1779\u20131786 (2018).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"13708_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.fertnstert.2018.10.013","volume":"111","author":"PR Koninckx","year":"2019","unstructured":"Koninckx, P. R. et al. Pathogenesis of endometriosis: the genetic\/epigenetic theory. Fertil. Steril. 111, 327\u2013340 (2019).","journal-title":"Fertil. Steril."},{"key":"13708_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1093\/humupd\/dmt052","volume":"20","author":"G Benagiano","year":"2014","unstructured":"Benagiano, G., Brosens, I. & Habiba, M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum. Reprod. Update 20, 386\u2013402 (2014).","journal-title":"Hum. Reprod. Update"},{"key":"13708_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/0002-9378(72)90781-8","volume":"112","author":"CC Bird","year":"1972","unstructured":"Bird, C. C., McElin, T. W. & Manalo-Estrella, P. The elusive adenomyosis of the uterus\u2014revisited. Am. J. Obstet. Gynecol. 112, 583\u2013593 (1972).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"13708_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1080\/14767058.2017.1285895","volume":"31","author":"A Hashimoto","year":"2018","unstructured":"Hashimoto, A. et al. Adenomyosis and adverse perinatal outcomes: increased risk of second trimester miscarriage, preeclampsia, and placental malposition. J. Matern. Fetal Neonatal Med. 31, 364\u2013369 (2018).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"13708_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/humupd\/dmv044","volume":"22","author":"S Vannuccini","year":"2016","unstructured":"Vannuccini, S. et al. Infertility and reproductive disorders: impact of hormonal and inflammatory mechanisms on pregnancy outcome. Hum. Reprod. Update 22, 104\u2013115 (2016).","journal-title":"Hum. Reprod. Update"},{"key":"13708_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.fertnstert.2007.06.027","volume":"90","author":"C Templeman","year":"2008","unstructured":"Templeman, C. et al. Adenomyosis and endometriosis in the California Teachers Study. Fertil. Steril. 90, 415\u2013424 (2008).","journal-title":"Fertil. Steril."},{"key":"13708_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.fertnstert.2017.12.030","volume":"109","author":"J Garc\u00eda-Solares","year":"2018","unstructured":"Garc\u00eda-Solares, J., Donnez, J., Donnez, O. & Dolmans, M.-M. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil. Steril. 109, 371\u2013379 (2018).","journal-title":"Fertil. Steril."},{"key":"13708_CR16","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.fertnstert.2018.01.013","volume":"109","author":"S Vannuccini","year":"2018","unstructured":"Vannuccini, S., Luisi, S., Tosti, C., Sorbi, F. & Petraglia, F. Role of medical therapy in the management of uterine adenomyosis. Fertil. Steril. 109, 398\u2013405 (2018).","journal-title":"Fertil. Steril."},{"key":"13708_CR17","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1210\/jc.2018-01227","volume":"103","author":"VA Flores","year":"2018","unstructured":"Flores, V. A., Vanhie, A., Dang, T. & Taylor, H. S. Progesterone receptor status predicts response to progestin therapy in endometriosis. J. Clin. Endocrinol. Metab. 103, 4561\u20134568 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"13708_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.1208930","volume":"334","author":"N Makinen","year":"2011","unstructured":"Makinen, N. et al. MED12, the mediator complex aubunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334, 252\u2013255 (2011).","journal-title":"Science"},{"key":"13708_CR19","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"G Getz","year":"2013","unstructured":"Getz, G. et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67\u201373 (2013).","journal-title":"Nature"},{"key":"13708_CR20","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","volume":"376","author":"MS Anglesio","year":"2017","unstructured":"Anglesio, M. S. et al. Cancer-associated mutations in endometriosis without cancer. N. Engl. J. Med. 376, 1835\u20131848 (2017).","journal-title":"N. Engl. J. Med."},{"key":"13708_CR21","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.celrep.2018.07.037","volume":"24","author":"K Suda","year":"2018","unstructured":"Suda, K. et al. Clonal expansion and diversification of cancer-associated mutations in endometriosis and normal endometrium. Cell Rep. 24, 1777\u20131789 (2018).","journal-title":"Cell Rep."},{"key":"13708_CR22","doi-asserted-by":"publisher","first-page":"eaaw0726","DOI":"10.1126\/science.aaw0726","volume":"364","author":"K Yizhak","year":"2019","unstructured":"Yizhak, K. et al. RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. Science 364, eaaw0726 (2019).","journal-title":"Science"},{"issue":"2","key":"13708_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/path.5314","volume":"249","author":"Vivian Lac","year":"2019","unstructured":"Lac, V. et al. Oncogenic mutations in histologically normal endometrium: the new normal? J. Pathol. 249, 173\u2013181 (2019). https:\/\/doi.org\/10.1002\/path.5314","journal-title":"The Journal of Pathology"},{"key":"13708_CR24","unstructured":"Moore, L. et al. The mutational landscape of normal human endometrial epithelium. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/505685v1 (2018)."},{"key":"13708_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","volume":"73","author":"S Sasagawa","year":"2008","unstructured":"Sasagawa, S. et al. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile. Steroids 73, 222\u2013231 (2008).","journal-title":"Steroids"},{"key":"13708_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ejogrb.2016.10.053","volume":"207","author":"A Takeuchi","year":"2016","unstructured":"Takeuchi, A. et al. Dienogest reduces proliferation, NGF expression and nerve fiber density in human adenomyosis. Eur. J. Obstet. Gynecol. Reprod. Biol. 207, 157\u2013161 (2016).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"13708_CR27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/IGC.0000000000000960","volume":"27","author":"KL Ring","year":"2017","unstructured":"Ring, K. L. et al. Endometrial cancers with activating KRas mutations have activated estrogen signaling and paradoxical response to MEK inhibition. Int. J. Gynecol. Cancer 27, 854\u2013862 (2017).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"13708_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/humupd\/dmu056","volume":"21","author":"B Patel","year":"2015","unstructured":"Patel, B. et al. Role of nuclear progesterone receptor isoforms in uterine pathophysiology. Hum. Reprod. Update 21, 155\u2013173 (2015).","journal-title":"Hum. Reprod. Update"},{"key":"13708_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4161\/epi.1.2.2766","volume":"1","author":"Y Wu","year":"2006","unstructured":"Wu, Y., Strawn, E., Basir, Z., Halverson, G. & Guo, S.-W. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 1, 106\u2013111 (2006).","journal-title":"Epigenetics"},{"key":"13708_CR30","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/aogs.13156","volume":"96","author":"BG Patel","year":"2017","unstructured":"Patel, B. G., Rudnicki, M., Yu, J., Shu, Y. & Taylor, R. N. Progesterone resistance in endometriosis: origins, consequences and interventions. Acta Obstetricia et. Gynecologica Scandinavica 96, 623\u2013632 (2017).","journal-title":"Acta Obstetricia et. Gynecologica Scandinavica"},{"key":"13708_CR31","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.27424","volume":"131","author":"DN Markowski","year":"2012","unstructured":"Markowski, D. N. et al. MED12 mutations in uterine fibroids-their relationship to cytogenetic subgroups. Int. J. Cancer 131, 1528\u20131536 (2012).","journal-title":"Int. J. Cancer"},{"key":"13708_CR32","doi-asserted-by":"crossref","unstructured":"Heikkinen, T. et al. MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas. Hum. Reprod. Open 2018, hoy020 (2018).","DOI":"10.1093\/hropen\/hoy020"},{"key":"13708_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.fertnstert.2015.08.026","volume":"104","author":"K Koga","year":"2015","unstructured":"Koga, K., Takamura, M., Fujii, T. & Osuga, Y. Prevention of the recurrence of symptom and lesions after conservative surgery for endometriosis. Fertil. Steril. 104, 793\u2013801 (2015).","journal-title":"Fertil. Steril."},{"key":"13708_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/GMIT.GMIT_35_18","volume":"7","author":"T Matsushima","year":"2018","unstructured":"Matsushima, T., Akira, S., Fukami, T., Yoneyama, K. & Takeshita, T. Efficacy of hormonal therapies for decreasing uterine volume in patients with adenomyosis. Gynecol. Minim. Invasive Ther. 7, 119\u2013123 (2018).","journal-title":"Gynecol. Minim. Invasive Ther."},{"key":"13708_CR35","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s00404-015-3755-5","volume":"292","author":"M Fawzy","year":"2015","unstructured":"Fawzy, M. & Mesbah, Y. Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial. Arch. Gynecol. Obstet. 292, 1267\u20131271 (2015).","journal-title":"Arch. Gynecol. Obstet."},{"key":"13708_CR36","doi-asserted-by":"publisher","first-page":"e1006853","DOI":"10.1371\/journal.pgen.1006853","volume":"13","author":"M Kawazu","year":"2017","unstructured":"Kawazu, M. et al. Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency. PLOS Genet. 13, e1006853 (2017).","journal-title":"PLOS Genet."},{"key":"13708_CR37","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1177\/1933719113518982","volume":"21","author":"X Li","year":"2014","unstructured":"Li, X. et al. Decreased DNA methylations at the progesterone receptor promoter A induce functional progesterone withdrawal in human parturition. Reprod. Sci. 21, 898\u2013905 (2014).","journal-title":"Reprod. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13708-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13708-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T02:34:33Z","timestamp":1671244473000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13708-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,19]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["13708"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-13708-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,19]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5785"}}